CN Patent

CN102757397A — 合成cetp抑制剂的方法

Assigned to Merck Sharp and Dohme LLC · Expires 2012-10-31 · 14y expired

What this patent protects

公开了制备为CETP抑制剂的化合物的有效方法。该方法的最后一步为 唑烷酮衍生物与联苯基部分的偶联以提供式(I)化合物。在该合成的具体实施方案中，制备的结晶产品特征为非溶剂化结晶多晶型物。

USPTO Abstract

公开了制备为CETP抑制剂的化合物的有效方法。该方法的最后一步为 唑烷酮衍生物与联苯基部分的偶联以提供式(I)化合物。在该合成的具体实施方案中，制备的结晶产品特征为非溶剂化结晶多晶型物。

Drugs covered by this patent

Patent Metadata

Patent number
CN102757397A
Jurisdiction
CN
Classification
—
Expires
2012-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.